Crestwood Advisors Group LLC Sells 615 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Crestwood Advisors Group LLC decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 3.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,284 shares of the financial services provider’s stock after selling 615 shares during the quarter. Crestwood Advisors Group LLC’s holdings in iShares Biotechnology ETF were worth $2,516,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of IBB. Blue Fin Capital Inc. lifted its holdings in iShares Biotechnology ETF by 0.7% in the second quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after buying an additional 74 shares during the period. Security National Bank of SO Dak lifted its holdings in iShares Biotechnology ETF by 0.7% in the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after buying an additional 75 shares during the period. SPC Financial Inc. lifted its holdings in iShares Biotechnology ETF by 2.4% in the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after buying an additional 75 shares during the period. Werba Rubin Papier Wealth Management lifted its holdings in iShares Biotechnology ETF by 2.7% in the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after buying an additional 76 shares during the period. Finally, Main Street Financial Solutions LLC lifted its holdings in iShares Biotechnology ETF by 1.0% in the second quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock valued at $1,098,000 after buying an additional 82 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.5 %

Shares of NASDAQ IBB opened at $145.06 on Wednesday. The firm’s 50-day moving average price is $144.86 and its 200-day moving average price is $140.84. iShares Biotechnology ETF has a 1-year low of $113.56 and a 1-year high of $150.57.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.